From: In silico regulatory analysis for exploring human disease progression
TF | Hypergeometric p-value | # of genes overlapped | Selected KEGG Pathways of targets shared with Wt1 |
---|---|---|---|
GLI1 | 0 | 36 | MapK Signalling, Tight Junction, Focal Adhesion |
MEF2A | 0 | 29 | MapK Signalling, Regulation of Actin Cytoskeleton |
NFIC | 0 | 16 | MapK Signalling, Regulation of Actin Cytoskeleton, Insulin Signalling |
E2F | 2.0e-12 | 52 | Calcium Signaling, Notch Signalling, Regulation of Actin Cytoskeleton, WNT Signalling |
SRF | 1.3e-10 | 11 | MapK Signalling |
POU5F1 | 6.2e-10 | 38 | Neuroactive Ligand Receptor Interaction, MapK Signalling |
YY1 | 3.8e-6 | 6 | MapK Signalling, Regulation of Actin Cytoskeleton |
SPI1 | 1.1e-3 | 4 | -- |
NANOG | 6.7e-3 | 23 | MapK Signalling, Regulation of Actin Cytoskeleton |
POU1F1 | 7.7e-3 | 1 | - |
CEBPB | 1.1e-2 | 6 | Neuroactive Ligand Receptor Interaction |
GATA1 | 1.5e-2 | 3 | MapK Signalling, Regulation of Actin Cytoskeleton |
T3R | 1.9e-2 | 2 | MapK Signalling |